OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 09, 2020
Interim analysis results from a phase 3 clinical trial reported a vaccine efficacy rate above 90% for BNT162b2. The trial is ongoing until it meets its threshold for confirmed COVID-19 cases.
November 03, 2020
The UK study examined the cross-sectional association between vitamins A, E, C, and D and respiratory complaints.
October 22, 2020
Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.
October 21, 2020
The study results indicate that clinicians should take cognitive dysfunction into account in the management of COPD.
CBD and its impacts on a protective peptide show that the cannabinoid may reduce lung inflammation and damage.
October 20, 2020
Results of a phase 3 trial showed clinical benefits with dupilumab (Dupixent; Sanofi and Regeneron) in children with uncontrolled moderate-to-severe asthma.
The meta-analysis accrued data from 18 studies that focused on patients with hospitalized and chronic heart failure.
October 16, 2020
In an open letter, Pfizer Chairman and CEO wrote that safety and efficacy data for its COVID-19 vaccine candidate may be ready by the third week of November for FDA submission.
October 13, 2020
An investigation examines whether an intervention including both school and home components improves asthma outcomes.
October 12, 2020
Help patients with upper respiratory infections choose an OTC product that’s right for them.
October 09, 2020
The BCG vaccine decreased the overall risk of new respiratory infections in elderly adults, according to the study results.
October 07, 2020
MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” on Tuesday, October 13, 2020 at 6 PM EDT.
October 01, 2020
Investigators reported that, compared with chemotherapy, atezolizumab monotherapy was superior in overall survival and progression-free survival in patients with NSCLC.
September 24, 2020
Tocilizumab (Actemra; Genentech) reduced the likelihood of needing mechanical ventilation in hospitalized patients with COVID-19 associated pneumonia.
September 22, 2020
Perrigo has issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol to the retail level.
A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.
September 21, 2020
Teva’s 2 digital inhalers for patients with asthma provide insight into objective inhaler use data.
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
September 15, 2020
Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.
September 10, 2020
Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta; GlaxoSmithKline) is indicated for the treatment of asthma in patients aged 18 years and older.